A white, cloudy suspension filled in a colorless, transparent syringe

Diphtheria Toxoid (Strain: 1514-N-3S) ≥20 IU, Tetanus Toxoid (Strain: 1472-C) ≥40 IU, Pertussis Toxoid (Strain: 1591) 25 μg, Filamentous Hemagglutinin (FHA) (Strain: 1591) 25 μg, Inactivated Poliovirus Type I (Strain: Mahoney) 40 DU, Inactivated Poliovirus Type II (Strain: MEF-1) 8 DU, Inactivated Poliovirus Type III (Strain: Saukett) 32 DU, Purified Hepatitis B Surface Antigen Protein (Recombinant) 10 μg, Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein in one pre-filled syringe (0.5mL)

Prevention of diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and invasive disease caused by Haemophilus influenzae type b (Hib) in infants aged 2 months and older.

Dosage

Primary Vaccination: Administer 3 doses of 0.5 mL each at 2, 4, and 6 months of age in infants who received a hepatitis B vaccine dose at birth.

Method of Administration

Administer intramuscularly (IM). The recommended injection site is the anterolateral aspect of the thigh.

Do not administer intravascularly, intradermally, or subcutaneously.

1 pre-filled syringe/box [Pre-filled syringe (0.5 mL)]

10 pre-filled syringes/box [Pre-filled syringe (0.5 mL)]

2 sterile needles

Store at 2~8℃, protected from light. Avoid freezing.